EP receptor agonists and other osteogenic therapies for bone repair

Drugs of the Future

Volumn 32, Issue 9, 2007, Pages 833-837

  Zaidi, Mone ^a   Zaidi, Neeha ^a   Sun, Li ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 [3 HYDROXY 2 [3 HYDROXY 4 (3 METHOXYMETHYLPHENYL) 1 BUTENYL] 5 OXOCYCLOPENTYL] 5 THIAHEPTANOIC ACID METHYL ESTER; AE 1329; CHRYSALIN; CP 533536; CP 734432; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PARATHYROID HORMONE; PEPTIDE; PLACEBO; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; RECOMBINANT PARATHYROID HORMONE; RUSALATIDE ACETATE; TP 508; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

BONE DEVELOPMENT; BONE REMODELING; CLINICAL TRIAL; CONTINUOUS INFUSION; DIARRHEA; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EXCRETION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG METABOLISM; DRUG STRUCTURE; FRACTURE HEALING; GROWTH RETARDATION; HUMAN; HYPOTENSION; MORPHOMETRICS; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; OSTEOTOMY; PROTEIN TARGETING; REVIEW; SEX DIFFERENCE; SINGLE DRUG DOSE;

EID: 36349019785     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2007.032.09.1124489     Document Type: Review

References (35)

1. 2 receptors in bone formation. Int Orthop 2007, E-pub ahead of print.
2. Iezzi, A., Ferri, C., Mezetti, A., Cipollone, F. COX-2: Friend or foe. Curr Pharm Des 2007, 13(16): 1715-21.
3. Li, M., Healy, D.R., Li, Y. et al. Osteopenia and impaired fracture healing in aged EP4 receptor mice. Bone 2005, 37(1): 46-57.
4. 2 in osteoblastic cell lines and adult rat bone tissue. Bone 2001, 28(3): 275-81.
5. Yoshida, K., Oida, H., Kobayashi, T. et al. Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proc Natl Acad Sci USA 2002, 99(7): 4580-5.
6. 2 receptor impairs osteoclastogenesis in vitro. Endocrinology 2000, 141(6): 2054-61.
7. 3-expressing bone marrow cells is crucial in wound-induced angiogenesis. Am J Pathol 2006, 169(4): 1458-72.
8. 2 on fracture callus in rabbits. Acta Orthop Scand 1993, 64(5): 59-63.
9. 2 agonist, in male and female Sprague-Dawley rats. Drug Metab Dispos 2005, 33(8): 1191-201.
10. 2 agonist stimulates local bone formation and enhances fracture healing. J Bone Miner Res 2003, 18(11): 2033-42.
11. 2 agonist induces bone healing. Proc Natl Acad Sci USA 2003, 100(11): 6736-40.
12. 2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats. Bone 2004, 34(6): 940-8.
13. 4 receptor-selective agonist facilitates sterna healing after harvesting bilateral internal thoracic arteries in diabetic rats. J Thorac Cardiovasc Surg 2006, 131(3): 587-93.
14. 2 agonist restores bone mass and strength in aged, ovariectomized rats. J Bone Miner Res 2006, 21(4): 565-75.
15. Johnson, K., Prakash, C., Shah, A., Jaw, J., Baxter, J. Metabolism, pharmacokinetics and excretion of a highly selective NMDA receptor antagonist, traxprodil, in human cytochrome P450 2D6 extensive and poor metabolizers. Drug Metab Dispos 2003, 31(1): 76-87.
16. Maurizis, J.C., Madelmont, J.C., Rapp, M. et al. Disposition and metabolism of 2,6-dimethylbenzamide N-(5-methyl-3-isoxazolyl) (D2916) in male and female rats. Drug Metab Dispos 1997, 25(1): 33-39.
17. Kobliakov, V., Popova, N., Rossi, L. Regulation of the expression of the sex-specific isoforms of cytochrome P450 in rat liver. Eur J Biochem 1991, 195(3): 585-91.
18. Praemer, A., Furner, S., Rice, D.P. (Eds.). Musculoskeletal Conditions in the United States. Am Acad Orth Surgeons: Park Ridge 1999, 185-224.
19. Den Boer F.C., Bramer, J.A., Blokhuis, T.J. et al. Effect of recombinant human osteogenic protein-1 on the healing of freshly closed disphyseal fractures. Bone 2002, 31(1): 158-64.
20. Govender, S., Csimma, C., Genant, H.K. et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fracture: A prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002, 84-A(12): 2123-34.
21. Axelrad, T.W., Kakar, S., Einhorn, T.A. New technologies for the enhancement of skeletal repair. Injury 2007, 38(Suppl. 1): S49-62.
22. Kim, C.S., Kim, J.I., Kim, J. et al. Ectopic bone formation associated with recombinant human bone morphogenetic protein-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers. Biomaterials 2005, 26(15): 2501-7.
23. Tarkka, T., Sipola, A., Jamsa, T. et al. Adenoviral VEGF-A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues. J Gene Med 2003, 5(7): 560-6.
24. Lee, Y.M., Park, Y.J., Lee, S.J. et al. The bone regenerative effect of platelet-derived growth factor-BB delivered with a chitosan/tricalcium phosphate sponge carrier. J Periodontol 2000, 71(3): 418-24.
25. Nevins, M., Gionnobile, W.V., McGuire, M.K. et al. Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: Results of a large multicenter randomized controlled trial. J Periodontol 2005, 76(12): 2205-15.
26. Nakajima, A., Shimoji, N., Shiomi, K. et al. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low dose human parathyroid hormone (1-34). J Bone Miner Res 2002, 17(11): 2038-47.
27. Skoglund, B., Forslund, C., Aspenberg, P. Simvastatin improves fracture healing in mice. J Bone Miner Res 2002, 17(11): 2004-8.
28. Zaidi, M. Skeletal remodeling in health and disease. Nat Med 2007, 13(7): 791-801.
29. Sheller, M.R., Crowther, R.S., Kinney, J.H. et al. Repair of rabbit segmental defects with the thrombin peptide, TP508. J Orthop Res 2004, 22(5): 1094-9.
30. 2 leds to localized tendon degeneration. Clin J Sport Med 2005, 15(1): 27-33.
31. Partridge, K., Yang, X., Clarke, N.M. et al. Adenoviral BMP-2 gene transfer in mesenchymal stem cells: In vitro and in vivo bone formation on biodegradable polymer scaffolds. Biochem Biophys Res Commun 2002, 292(1): 144-52.
32. Lee J.Y., Qu-Petersen, Z., Cao, B. et al. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 2000, 150(5): 1085-100.
33. Matsumoto, T., Kawamoto, A., Kuroda, R. et al. Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone leaking. Am J Pathol 2006, 169(4): 1440-57.
34. Eghbali-Fatourechi, G.Z., Lamsam, J., Fraser, D., Nagel, D., Riggs, B.L., Khosla, S. Circulating osteoblast-lineage cells in humans. New Eng J Med 2005, 352(19): 1959-66.
35. Bilic-Curcic, I., Kalajzic, Z., Wang, L., Rowe, D.W. Origins of endothelial and osteogenic cells in the subcutaneous collagen gel implant. Bone 2005, 37(5): 678-87.